Steffen Nyegaard

Steffen N. is an accomplished professional in the pharmaceutical and biotechnology sectors, currently serving as Associate Director at Ascendis Pharma since July 2021, focusing on new product opportunities and technology platforms. Prior experience includes Senior Manager of Product Innovation, where responsibilities encompassed oncology and rare endocrinology product leads, and Head of Research and Development at Svar Life Science AB, concentrating on inflammatory and autoimmune diseases. Steffen N. has also held positions at Lundbeck, including Project Manager for drug development in Parkinson’s disease, and various roles in research and academia, including postdoctoral fellowships at the University of Toronto and Aarhus University. Steffen N. holds a Ph.D. in Molecular Biology from Aarhus University and has extensive expertise in drug development and research related to neurodegeneration and inflammation.